Clinical Trial Update: Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema [NA]

View source ↗

Summary

A completed clinical trial comparing brolucizumab and aflibercept in diabetic macular edema evaluated visual and anatomical outcomes. The study was sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• BEOVU (BROLUCIZUMAB)
• EYLEA (Aflibercept)

Snippet

Sponsor: Benha University | Conditions: Anti-VEGF Therapy | NA | Status: COMPLETED